Arecor attends the 37TH annual JP Morgan Healthcare Conference


Arecor Ltd, the UK-based specialty pharmaceutical company that develops superior biopharmaceuticals through the application of an innovative formulation technology platform, will be attending the 37th Annual JP Morgan Healthcare Conference in San Francisco, California, next month.

Arecor’s executive management team, Dr Sarah Howell (Chief Executive Officer) and Dr Jan Jezek (Chief Scientific Officer) will be at the conference, which takes place January 7-10, 2019 at the Westin St. Francis Hotel, 335 Powell St, San Francisco.

Arecor will be available for one-on-one meetings and gladly welcomes the opportunity to discuss in more detail, both the Company’s clinical-stage portfolio of proprietary products that will enable improved treatments for diabetes, as well as partnering opportunities within its technology business, in which the Company partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.

To arrange a one-on-one meeting with Arecor’s management team in San Francisco, please contact:
Maggie McConnell
Office Manager/PA
Tel: +44 (0)1223 426060


Advancing today's therapies to enable healthier lives.

Arecor Therapeutics Plc